The Net Margin of Immune Therapeutics Inc (IMUN) is -7202.85%.
Net Margin measures the percentage of net income derived from total revenue after all expenses. It signals how much actual profit a company retains from its sales.
| Date | Value |
|---|---|
| 2022-12-31 | -7202.85% |
| 2021-12-31 | -7202.85% |
| 2020-12-31 | -564202.30% |
| 2019-12-31 | -87916.73% |